Key result
Percutaneous valve interventions, including aortic valve replacement and mitral valve repair, have revolutionized the management of patients with valvular heart disease.
This review summarizes recent advances in the management of valvular heart disease, emphasizing the role of emerging percutaneous interventions for complex, aging patients.
Answers are grounded in this paper and cite their sources.
May guide decisions for complex valvular patients; extends prior reviews but leaves open need for prospective trials.
With an ageing population and improved diagnostic modalities, the number of patients with valvular heart disease is dramatically increasing. We are faced with more complex decisions in patients with advanced age and increasing comorbidities. Advances in percutaneous valve interventions – like percutaneous aortic valve replacement and mitral valve repair – have revolutionised the way we manage such diseases. This overview highlights recent advances in the decision making – process and the management of patients with valvular heart disease.
No takes yet. Share an insight, caveat, or question.
Raphaël Rosenhek (2012) conducted a review in Valvular heart disease. Percutaneous valve interventions was evaluated. Percutaneous valve interventions, including aortic valve replacement and mitral valve repair, have revolutionized the management of patients with valvular heart disease.
Synapse has enriched 10 related papers. Consider them for comparative context: